Researchers at the Technical University of Munich (TUM) have increased the effectiveness of a standard antibiotic by a factor ...

Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be prevented by screening for and treating a common bacterial infection: ...

Please provide your email address to receive an email when new articles are posted on . Concomitant and bismuth quadruple therapies had success rates of nearly 90% for initial treatment of H. pylori.

News and commentary from the world of gastroenterology and hepatology ...

A new study has found that Helicobacter pylori, or H. pylori, a common bacteria that infects nearly half the global population, could be a major driver of stomach cancer worldwide. Researchers ...

Researchers at the Technical University of Munich have developed a new drug candidate that significantly enhances the effectiveness of the antibiotic metronidazole against Helicobacter pylori, a ...

Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...

The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) infection. The number one recommendation for treatment-naive patients is ...

It is something that nearly 36 percent of U.S. adults are infected with at some point. Normally, H. pylori can be treated with antibiotics early on, but when left untreated can lead to detrimental ...

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region. Approximately 90% of cases are linked to H.

Background and Aims: The adjuvant effects of probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori (H. pylori) infection have not been evaluated. Methods: A total of 337 ...